HISTAMINE PHOSPHATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for histamine phosphate and what is the scope of freedom to operate?
Histamine phosphate
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for HISTAMINE PHOSPHATE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 75 |
| Clinical Trials: | 1 |
| Patent Applications: | 233 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for HISTAMINE PHOSPHATE |
| What excipients (inactive ingredients) are in HISTAMINE PHOSPHATE? | HISTAMINE PHOSPHATE excipients list |
| DailyMed Link: | HISTAMINE PHOSPHATE at DailyMed |
Recent Clinical Trials for HISTAMINE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kuopio University Hospital | N/A |
Medical Subject Heading (MeSH) Categories for HISTAMINE PHOSPHATE
Anatomical Therapeutic Chemical (ATC) Classes for HISTAMINE PHOSPHATE
US Patents and Regulatory Information for HISTAMINE PHOSPHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
